People with type 2 diabetes who are taking a GLP-1 now have a newly branded option for treatment. Novo Nordisk, which makes the GLP-1 semaglutide medications Ozempic and Wegovy, announced that it’s ...

Learn about the current medication options for managing type 2 diabetes and chronic kidney disease, including SGLT2 ...

Weight loss achieved with GLP-1 drugs such as Ozempic, Wegovy and Mounjaro is linked to sharply lower risks of serious ...

A recent study found that GLP-1 medications like Ozempic and Wegovy may help improve breast cancer survival rates among women ...

A daily pill from drugmaker Eli Lilly has shown similar effectiveness at helping people reduce blood sugar levels and lose weight compared to leading injectable GLP-1 drugs Mounjaro and Ozempic, the ...

Popular weight-loss and type 2 diabetes drugs such as Wegovy and Ozempic are typically taken as self-administered injections—a bearable albeit unpleasant jab to the abdomen or thigh. But drug ...

Some health-obsessed Americans believe the next antiaging therapeutic already exists—in the medicine cabinets of millions of diabetes patients. The widely used class of drugs, called SGLT2 inhibitors ...

The alphabet soup that's being dished out for the newer Type 2 diabetes medications can be pretty confusing. So let me spell it out for one of them: SGLT-2 inhibitors. These sodium-glucose ...

Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...

The search for effective dementia prevention continues to challenge medical researchers worldwide. Now, a major study published in JAMA Neurology reveals that certain medications used to treat type 2 ...

The treatment landscape for type 2 diabetes has long been dominated by pharmaceutical approaches that manage symptoms without addressing the underlying metabolic dysfunction. While medications play an ...